{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T15:49:08Z","timestamp":1765208948493,"version":"3.46.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,8]]},"DOI":"10.7759\/cureus.98716","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T15:00:41Z","timestamp":1765206041000},"source":"Crossref","is-referenced-by-count":0,"title":["Immunodeficiency in Children With Invasive Pneumococcal Disease"],"prefix":"10.7759","author":[{"given":"Ahmed M","family":"Almesfer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed M","family":"AlSaiary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad M","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami I","family":"Alradhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2019.3203","article-title":"Prevalence of immunodeficiency in children with invasive pneumococcal disease in the pneumococcal vaccine era: a systematic review","volume":"173","author":"Butters C","year":"2019","unstructured":"Butters C, Phuong LK, Cole T, Gwee A. Prevalence of immunodeficiency in children with invasive pneumococcal disease in the pneumococcal vaccine era: a systematic review. JAMA Pediatr. 2019, 173:1084-94. 10.1001\/jamapediatrics.2019.3203","journal-title":"JAMA Pediatr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.33321\/cdi.2003.27.75","article-title":"Invasive pneumococcal disease in Australia, 2002","volume":"27","author":"Roche P","year":"2003","unstructured":"Roche P, Krause V, Andrews R, et al.. Invasive pneumococcal disease in Australia, 2002. Commun Dis Intell Q Rep. 2003, 27:466-77. 10.33321\/cdi.2003.27.75","journal-title":"Commun Dis Intell Q Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.33321\/cdi.2022.46.28","article-title":"Summary of national surveillance data on vaccine preventable diseases in Australia, 2016-2018 final report","volume":"46","author":"Patel C","year":"2022","unstructured":"Patel C, Dey A, Wang H, McIntyre P, Macartney K, Beard F. Summary of national surveillance data on vaccine preventable diseases in Australia, 2016-2018 final report. Commun Dis Intell (2018). 2022, 46:10.33321\/cdi.2022.46.28","journal-title":"Commun Dis Intell (2018)"},{"key":"ref4","unstructured":"National Notifiable Diseases Surveillance System (NNDSS) public dataset - pneumococcal disease (invasive). (2025). https.\/\/www.health.gov.au\/resources\/publications\/national-notifiable-diseases-surveillance-system-nndss-public-datase...."},{"key":"ref5","unstructured":"Pneumococcal disease surveillance and trends. Accessed. November 8, 2025: https:\/\/www.cdc.gov\/pneumococcal\/php\/surveillance\/index.html."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1871","article-title":"The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease","volume":"6","author":"Kadioglu A","year":"2008","unstructured":"Kadioglu A, Weiser JN, Paton JC, Andrew PW. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol. 2008, 6:288-301. 10.1038\/nrmicro1871","journal-title":"Nat Rev Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-818731-9.00043-4","article-title":"General concepts of immunity","volume":"1","author":"Rezaei N","year":"2022","unstructured":"Rezaei N, Sadeghalvad M, Mohammadi-Motlagh HR. General concepts of immunity. Encycl Infect Immun. 2022, 1:1-13. 10.1016\/B978-0-12-818731-9.00043-4","journal-title":"Encycl Infect Immun"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2015.02.001","article-title":"Complement: an overview for the clinician","volume":"29","author":"Varela JC","year":"2015","unstructured":"Varela JC, Tomlinson S. Complement: an overview for the clinician. Hematol Oncol Clin North Am. 2015, 29:409-27. 10.1016\/j.hoc.2015.02.001","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq6399","article-title":"Splenic red pulp macrophages eliminate the liver-resistant Streptococcus pneumoniae from the blood circulation of mice","volume":"11","author":"An H","year":"2025","unstructured":"An H, Huang Y, Zhao Z, et al.. Splenic red pulp macrophages eliminate the liver-resistant Streptococcus pneumoniae from the blood circulation of mice. Sci Adv. 2025, 11:eadq6399. 10.1126\/sciadv.adq6399","journal-title":"Sci Adv"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan T","year":"2022","unstructured":"Duan T, Du Y, Xing C, Wang HY, Wang RF. Toll-like receptor signaling and its role in cell-mediated immunity. Front Immunol. 2022, 13:812774. 10.3389\/fimmu.2022.812774","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu274","article-title":"Invasive pneumococcal disease in children can reveal a primary immunodeficiency","volume":"59","author":"Gaschignard J","year":"2014","unstructured":"Gaschignard J, Levy C, Chrabieh M, et al.. Invasive pneumococcal disease in children can reveal a primary immunodeficiency. Clin Infect Dis. 2014, 59:244-51. 10.1093\/cid\/ciu274","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000701","article-title":"Immunodeficiency among children with recurrent invasive pneumococcal disease","volume":"34","author":"Ingels H","year":"2015","unstructured":"Ingels H, Schejbel L, Lundstedt AC, et al.. Immunodeficiency among children with recurrent invasive pneumococcal disease. Pediatr Infect Dis J. 2015, 34:644-51. 10.1097\/INF.0000000000000701","journal-title":"Pediatr Infect Dis J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003554","article-title":"Screening for immunodeficiencies in children with invasive pneumococcal disease: six-year experience from a UK children\u2019s hospital","volume":"41","author":"Bijker EM","year":"2022","unstructured":"Bijker EM, Bateman EA, Tr\u00fcck J, Patel S, Kelly DF. Screening for immunodeficiencies in children with invasive pneumococcal disease: six-year experience from a UK children\u2019s hospital. Pediatr Infect Dis J. 2022, 41:575-8. 10.1097\/INF.0000000000003554","journal-title":"Pediatr Infect Dis J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000004004","article-title":"Inborn errors of immunity in children with invasive pneumococcal disease: a multicenter prospective study","volume":"42","author":"Phuong LK","year":"2023","unstructured":"Phuong LK, Cheung A, Agrawal R, et al.. Inborn errors of immunity in children with invasive pneumococcal disease: a multicenter prospective study. Pediatr Infect Dis J. 2023, 42:908-13. 10.1097\/INF.0000000000004004","journal-title":"Pediatr Infect Dis J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.05.022","article-title":"Inborn errors of immunity underlying a susceptibility to pyogenic infections: from innate immune system deficiency to complex phenotypes","volume":"28","author":"Conti F","year":"2022","unstructured":"Conti F, Marzollo A, Moratti M, Lodi L, Ricci S. Inborn errors of immunity underlying a susceptibility to pyogenic infections: from innate immune system deficiency to complex phenotypes. Clin Microbiol Infect. 2022, 28:1422-8. 10.1016\/j.cmi.2022.05.022","journal-title":"Clin Microbiol Infect"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01352-z","article-title":"The 2022 update of IUIS phenotypical classification for human inborn errors of immunity","volume":"42","author":"Bousfiha A","year":"2022","unstructured":"Bousfiha A, Moundir A, Tangye SG, et al.. The 2022 update of IUIS phenotypical classification for human inborn errors of immunity. J Clin Immunol. 2022, 42:1508-20. 10.1007\/s10875-022-01352-z","journal-title":"J Clin Immunol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.549","article-title":"Toll-like receptors in health and disease","volume":"5","author":"Wang K","year":"2024","unstructured":"Wang K, Huang H, Zhan Q, Ding H, Li Y. Toll-like receptors in health and disease. MedComm (2020). 2024, 5:e549. 10.1002\/mco2.549","journal-title":"MedComm (2020)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.625753","article-title":"Primary immunodeficiencies: a decade of progress and a promising future","volume":"11","author":"Meyts I","year":"2020","unstructured":"Meyts I, Bousfiha A, Duff C, et al.. Primary immunodeficiencies: a decade of progress and a promising future. Front Immunol. 2020, 11:625753. 10.3389\/fimmu.2020.625753","journal-title":"Front Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11071816","article-title":"Systematic literature review of the epidemiological characteristics of pneumococcal disease caused by the additional serotypes covered by the 20-valent pneumococcal conjugate vaccine","volume":"11","author":"M\u00e9roc E","year":"2023","unstructured":"M\u00e9roc E, Fletcher MA, Hanquet G, et al.. Systematic literature review of the epidemiological characteristics of pneumococcal disease caused by the additional serotypes covered by the 20-valent pneumococcal conjugate vaccine. Microorganisms. 2023, 11:1816. 10.3390\/microorganisms11071816","journal-title":"Microorganisms"},{"key":"ref20","unstructured":"WHO position paper. pneumococcal conjugate vaccines in infants and children under 5 years of age. (2019). https:\/\/www.who.int\/publications\/i\/item\/10665-310968."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-063039","article-title":"Invasive pneumococcal disease after 2 decades of pneumococcal conjugate vaccine use","volume":"153","author":"Yildirim I","year":"2024","unstructured":"Yildirim I, Lapidot R, Shaik-Dasthagirisaheb YB, et al.. Invasive pneumococcal disease after 2 decades of pneumococcal conjugate vaccine use. Pediatrics. 2024, 153:10.1542\/peds.2023-063039","journal-title":"Pediatrics"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s41479-022-00103-3","article-title":"Incidence of pneumococcal disease from 2003 to 2019 in children \u226417\u2009years in England","volume":"15","author":"Mohanty S","year":"2023","unstructured":"Mohanty S, Podmore B, Cu\u00f1ado Moral A, Matthews I, Sarpong E, Lacetera A, Qizilbash N. Incidence of pneumococcal disease from 2003 to 2019 in children \u226417\u2009years in England. Pneumonia (Nathan). 2023, 15:2. 10.1186\/s41479-022-00103-3","journal-title":"Pneumonia (Nathan)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12101197","article-title":"Burden of pneumococcal disease in young children due to serotypes contained in different pneumococcal conjugate vaccines in eight Asian countries and territories","volume":"12","author":"Huang L","year":"2024","unstructured":"Huang L, Li X, Eugenia N, et al.. Burden of pneumococcal disease in young children due to serotypes contained in different pneumococcal conjugate vaccines in eight Asian countries and territories. Vaccines (Basel). 2024, 12:1197. 10.3390\/vaccines12101197","journal-title":"Vaccines (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9121390","article-title":"Pneumococcal immunization strategies for high-risk pediatric populations worldwide: one size does not fit all","volume":"9","author":"Lagousi T","year":"2021","unstructured":"Lagousi T, Papadatou I, Strempas P, Chatzikalil E, Spoulou V. Pneumococcal immunization strategies for high-risk pediatric populations worldwide: one size does not fit all. Vaccines (Basel). 2021, 9:1390. 10.3390\/vaccines9121390","journal-title":"Vaccines (Basel)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228799","article-title":"Population-based incidence and serotype distribution of invasive pneumococcal disease prior to introduction of conjugate pneumococcal vaccine in Bangladesh","volume":"15","author":"Baqui AH","year":"2020","unstructured":"Baqui AH, McCollum ED, Mahmud A, et al.. Population-based incidence and serotype distribution of invasive pneumococcal disease prior to introduction of conjugate pneumococcal vaccine in Bangladesh. PLoS ONE. 2020, 15:e0228799. 10.1371\/journal.pone.0228799","journal-title":"PLoS ONE"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-018-0001-8","article-title":"Streptococcus pneumoniae: transmission, colonization and invasion","volume":"16","author":"Weiser JN","year":"2018","unstructured":"Weiser JN, Ferreira DM, Paton JC. Streptococcus pneumoniae: transmission, colonization and invasion. Nat Rev Microbiol. 2018, 16:355-67. 10.1038\/s41579-018-0001-8","journal-title":"Nat Rev Microbiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2005.00235.x","article-title":"Inherited disorders of human Toll-like receptor signaling: immunological implications","volume":"203","author":"Ku CL","year":"2005","unstructured":"Ku CL, Yang K, Bustamante J, et al.. Inherited disorders of human Toll-like receptor signaling: immunological implications. Immunol Rev. 2005, 203:10-20. 10.1111\/j.0105-2896.2005.00235.x","journal-title":"Immunol Rev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181fd8ec3","article-title":"Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency","volume":"89","author":"Picard C","year":"2010","unstructured":"Picard C, von Bernuth H, Ghandil P, et al.. Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine (Baltimore). 2010, 89:403-25. 10.1097\/MD.0b013e3181fd8ec3","journal-title":"Medicine (Baltimore)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.26255","article-title":"Genome-wide identification of lineage and locus specific variation associated with pneumococcal carriage duration","volume":"6","author":"Lees JA","year":"2017","unstructured":"Lees JA, Croucher NJ, Goldblatt D, et al.. Genome-wide identification of lineage and locus specific variation associated with pneumococcal carriage duration. Elife. 2017, 6:e26255. 10.7554\/eLife.26255","journal-title":"Elife"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61114-4","article-title":"Pathogenesis, treatment, and prevention of pneumococcal pneumonia","volume":"374","author":"van der Poll T","year":"2009","unstructured":"van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet. 2009, 374:1543-56. 10.1016\/S0140-6736(09)61114-4","journal-title":"Lancet"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-200204000-00004","article-title":"Invasive pneumococcal infections in children with asplenia","volume":"21","author":"Schutze GE","year":"2002","unstructured":"Schutze GE, Mason EO Jr, Barson WJ, et al.. Invasive pneumococcal infections in children with asplenia. Pediatr Infect Dis J. 2002, 21:278-82. 10.1097\/00006454-200204000-00004","journal-title":"Pediatr Infect Dis J"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1086\/590006","article-title":"Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection","volume":"47","author":"Eisen DP","year":"2008","unstructured":"Eisen DP, Dean MM, Boermeester MA, et al.. Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin Infect Dis. 2008, 47:510-6. 10.1086\/590006","journal-title":"Clin Infect Dis"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178377","article-title":"Mannose-binding lectin-deficient genotypes as a risk factor of pneumococcal meningitis in infants","volume":"12","author":"Bautista-Rodriguez C","year":"2017","unstructured":"Bautista-Rodriguez C, Launes C, Jordan I, et al.. Mannose-binding lectin-deficient genotypes as a risk factor of pneumococcal meningitis in infants. PLoS One. 2017, 12:e0178377. 10.1371\/journal.pone.0178377","journal-title":"PLoS One"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.07.053","article-title":"Primary immunodeficiencies","volume":"125","author":"Notarangelo LD","year":"2010","unstructured":"Notarangelo LD. Primary immunodeficiencies. J Allergy Clin Immunol. 2010, 125:S182-94. 10.1016\/j.jaci.2009.07.053","journal-title":"J Allergy Clin Immunol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3201\/eid2801.210734","article-title":"Serotype replacement after introduction of 10-valent and 13-valent pneumococcal conjugate vaccines in 10 countries, Europe","volume":"28","author":"Hanquet G","year":"2022","unstructured":"Hanquet G, Krizova P, Dalby T, et al.. Serotype replacement after introduction of 10-valent and 13-valent pneumococcal conjugate vaccines in 10 countries, Europe. Emerg Infect Dis. 2022, 28:137-8. 10.3201\/eid2801.210734","journal-title":"Emerg Infect Dis"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1564444","article-title":"Invasive pneumococcal disease in relation to vaccine type serotypes","volume":"15","author":"Wantuch PL","year":"2019","unstructured":"Wantuch PL, Avci FY. Invasive pneumococcal disease in relation to vaccine type serotypes. Hum Vaccin Immunother. 2019, 15:874-5. 10.1080\/21645515.2018.1564444","journal-title":"Hum Vaccin Immunother"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit816","article-title":"Executive summary: 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin LG","year":"2014","unstructured":"Rubin LG, Levin MJ, Ljungman P, et al.. Executive summary: 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014, 58:309-18. 10.1093\/cid\/cit816","journal-title":"Clin Infect Dis"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7401a1","article-title":"Expanded recommendations for use of pneumococcal conjugate vaccines among adults aged \u226550 years: recommendations of the advisory committee on immunization practices \u2014 United States, 2024","volume":"74","author":"Kobayashi M","year":"2025","unstructured":"Kobayashi M, Leidner AJ, Gierke R, et al.. Expanded recommendations for use of pneumococcal conjugate vaccines among adults aged \u226550 years: recommendations of the advisory committee on immunization practices \u2014 United States, 2024. MMWR Morb Mortal Wkly Rep. 2025, 74:1-8. 10.15585\/mmwr.mm7401a1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000004318","article-title":"A phase 3, single-arm trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in healthy children 15 months through <18 years of age","volume":"43","author":"Meyer J","year":"2024","unstructured":"Meyer J, Silas P, Ouedraogo GL, et al.. A phase 3, single-arm trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in healthy children 15 months through &lt;18 years of age. Pediatr Infect Dis J. 2024, 43:574-81. 10.1097\/INF.0000000000004318","journal-title":"Pediatr Infect Dis J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/441760-immunodeficiency-in-children-with-invasive-pneumococcal-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T15:00:43Z","timestamp":1765206043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/441760-immunodeficiency-in-children-with-invasive-pneumococcal-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":39,"URL":"https:\/\/doi.org\/10.7759\/cureus.98716","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,8]]}}}